Clinical trial
Crizotinib Expanded Access Protocol For ROS1 Positive NSCLC
NCT02824094
Study timeline
Registry last updated2017-07-21
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Neoplasmsunresolved
Carcinoma, Non-Small-Cell Lungunresolved
Interventions
crizotinibDRUG · verified · RxNorm: crizotinib
Sponsors & collaborators
Pfizerlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02824094 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.